The latest announcement is out from Maravai Lifesciences Holdings (MRVI).
Maravai LifeSciences Holdings, Inc. has appointed William “Trey” Martin, III as a new board member, starting July 31, 2024. His term will continue until the 2026 annual stockholders meeting. Martin, who is also the company’s CEO, won’t receive extra pay for this role. His appointment is independent of any personal or material interests that need disclosure. The company has issued a press release on this board change.
For an in-depth examination of MRVI stock, go to TipRanks’ Stock Analysis page.
